Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 891-900

  Brown, J C ^a   Shanahan, P M A ^a   Jesudason, M V ^b   Thomson, C J ^a   Amyes, S G B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CIPROFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PHENYLALANINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TYROSINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; GENE SEQUENCE; INDIA; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA TYPHI;

AMINO ACID SEQUENCE; BASE SEQUENCE; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NALIDIXIC ACID; OFLOXACIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUINOLONES; SALMONELLA TYPHI;

EID: 0029890803     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.891     Document Type: Article

References (26)

1. Anand, A. C., Kataria, V. K., Singh, W. & Chatterjee, S. K. (1990). Epidemic multiresistant enteric fever in eastern India. Lancet 335, 352.
2. Antani, D. V., Kala, V. V. & Kawat, S. A. (1988). Salmonella susceptibility to chloramphenicol and clinical response to enteric fever, Journal of the Association of Physicians of India 36, 649-50.
3. Bhatia, R. S. (1992). Typhoid fever, not responding to ciprofloxacin therapy. Journal of the Association of Physicians of India 40, 705-6.
4. Brown, J. C., Thomson, C. J. & Amyes, S. G. B. (1976). Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. Journal of Antimicrobial Chemotherapy 37, 359-66.
5. Farid, Z. (1992). Multiresistant Salmonella typhi infection in Cairo. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 224.
6. Fisher, L. M., Lawrence, J. M., Josty, I. C., Hopewell, R, Margerrison, E. E. C. & Cullen, M. E. (1989). Ciprofloxacin and the fluroquinolones. American Journal of Medicine 87, Suppl. 5A, 2-8.
7. Goldstein, F. W., Chumpitaz, J. C., Guevara, J. M., Papadopoulou, B., Acar, J. F. & Vieu, J. F. (1986). Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. Journal of Infectious Diseases 153, 261-6.
8. Gupta, B. L., Bhujwala, R. A. & Shriniwas. (1990). Multiresistant Salmonella typhi in India. Lancet 336, 252.
9. Jesudason, M. V. & John, T. J. (1992). Plasmid mediated multidrug resistance in Salmonella typhi. Indian Journal of Medical Research 95, 66-7.
10. Khadilkar, V. V., Khubchandani, R. P., Amdekar, Y. K., Mehta, K. P. & Anand, R. K. (1990). Drug resistant typhoid fever: an emerging problem. Indian Pediatrics 27, 1227-8.
11. Lewin, C. S., Nandivada, L. S. & Amyes, S. G. B. (1991). Multiresistant Salmonella and fluroquinolones. Journal of Antimicrobial Chemotherapy 27, 147-9.
12. Reece, R. J. & Maxwell, A. (1991). DNA gyrase: structure and function. Critical Reviews in Biochemistry and Molecular Biology 26, 335-75.
13. Rowe, B., Ward, L. R. & Threlfall, E. J. (1990). Spread of multiresistant Salmonella typhi. Lancet 336, 1065.
14. Rowe, B., Ward, L. R. & Threlfall, E. J. (1991). Treatment of multiresistant typhoid fever. Lancet 337, 1422.
15. Rowe, B., Ward, L. R. & Threlfall, E. J. (1992). Ciprofloxacin and typhoid fever. Lancet 339, 740.
16. Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA Sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Science USA 74, 5463-7.
17. Schwalbe, R. S., Hoge, C. W., Morriss, J. G., O'Hanlon, P. N., Crawford, R. A. & Gilligan, P. H. (1990). In vivo selection for transmissable drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrobial Agents and Chemotherapy 34, 161-3.
18. Sharma, K. B., Bheem Bhatt, M., Pasricha, A. & Vaze, S. (1979). Multiple antibiotic resistance among salmonellae in India. Journal of Antimicrobial Chemotherapy 5, 15-21.
19. Shen, L. L., Mitscher, L. A., Sharma, P. N., O'DonnelJ, T. J., Chu, D W., Cooper, C. S., et al. (1989). Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a co-operative drug-DNA binding model. Biochemistry 28, 3886-94.
20. Umasankar, S., Wall, R. A. & Berger, J. (1992). A case of ciprofloxacin-resistant typhoid fever. Communicable Disease Report. CDR Review 2, R139-40.
21. Wiedemann, B. & Heisig, P. (1994). Mechanisms of quinolone resistance. Infection 22, Suppl. 2, 73-79.
22. Willmott, C. J. R., Critchlow, S. E., Eperon, I. C. & Maxwell, A. (1994). The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. Journal of Molecular Biology 242, 351-63.
23. Willmott, C. J. R. & Maxwell, A. (1993). A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrobial Agents and Chemotherapy 37, 126-7.
24. Yoshida, H., Bogaki, M., Nakamura, M. & Nakamura, S. (1990). Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrobial Agents and Chemotherapy 34, 1271-2.
25. Yoshida, H., Kojima, T., Yamagishi, J. & Nakamura, S. (1988). Quinolone resistant mutations of the gyrA gene of Escherichia coli. Molecular and General Genetics 211, 1-7.
26. Zyskind, J. W. & Bernstein, S. I. (1992). Isolation and analysis of bacterial and Drosophila chromosomal DNA. In Recombinant DNA Laboratory Manual, pp. 11-15. Academic Press, Inc. San Diego.